Skip to content

OSTEODUO: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

OSTEODUO

BE 0867.694.296
NACE 86.210, General medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€329
2024 · €13,839-€13,510
Equity
-€17,681
2024 · -€18,010+€329
Cash
-
2024 · €1,936-€1,936
Balance sheet total
€2,399
2024 · €3,875-€1,476

Largest movements

2024 to 2025
Assets
  • Cash -€1,936

    no longer reported in 2025 (was €1,936)

    mainly Other debts (-€1,267) and Receivables within one year (-€1,225)

  • Receivables within one year +€1,225

    up €1,225 (+132.5%), from €924 to €2,149

    of which Trade receivables: +€692

  • Deferred charges and accrued income -€765

    no longer reported in 2025 (was €765)

Equity and liabilities
  • Other debts -€1,267

    down €1,267 (-6.4%), from €19,752 to €18,485

  • Trade debts -€539

    down €539 (-71.8%), from €750 to €212

  • Profit (loss) carried forward +€329

    up €329 (+0.7%), from -€50,449 to -€50,120

Income statement
  • Gross operating margin -€14,871

    down €14,871 (-93.9%), from €15,837 to €966

  • Taxes -€1,384

    no longer reported in 2025 (was €1,384)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €13,839
Gross operating margin -€14,871
Other operating charges +€6
Financial charges -€29
Taxes +€1,384
Result 2025 €329

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€1,936
Investment €0
Financing €0
Cash 2024 €1,936
Net result for the year +€329
Receivables within one year -€1,225
Deferred charges and accrued income +€765
Trade debts -€539
Other debts -€1,267
Cash 2025 €0
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,875 €2,399 -€1,476 -38.1%
Fixed assets 21/28 €250 €250 = 0.0%
Financial fixed assets 28 €250 €250 = 0.0%
Current assets 29/58 €3,625 €2,149 -€1,476 -40.7%
Amounts receivable within one year 40/41 €924 €2,149 +€1,225 +132.5%
Trade receivables 40 €924 €1,617 +€692 +74.9%
Other amounts receivable 41 - €532 +€532
Cash at bank and in hand 54/58 €1,936 - -€1,936
Deferred charges and accrued income 490/1 €765 - -€765
Total equity and liabilities 10/49 €3,875 €2,399 -€1,476 -38.1%
Equity 10/15 -€18,010 -€17,681 +€329 +1.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €13,839 €13,839 = 0.0%
Distributable reserves 133 €13,839 €13,839 = 0.0%
Profit (loss) carried forward 14 -€50,449 -€50,120 +€329 +0.7%
Amounts payable 17/49 €21,885 €20,080 -€1,805 -8.2%
Amounts payable within one year 42/48 €21,885 €20,080 -€1,805 -8.2%
Trade debts 44 €750 €212 -€539 -71.8%
Suppliers 440/4 €750 €212 -€539 -71.8%
Taxes, remuneration and social security 45 €1,384 €1,384 = 0.0%
Taxes 450/3 €1,384 €1,384 = 0.0%
Other amounts payable 47/48 €19,752 €18,485 -€1,267 -6.4%
Other operating charges 640/8 €471 €465 -€6 -1.3%
Gross operating margin 9900 €15,837 €966 -€14,871 -93.9%
Operating profit (loss) 9901 €15,366 €500 -€14,865 -96.7%
Financial charges 65/66B €142 €172 +€29 +20.4%
Recurring financial charges 65 €142 €172 +€29 +20.4%
Profit (loss) for the period before taxes 9903 €15,223 €329 -€14,894 -97.8%
Income taxes 67/77 €1,384 - -€1,384
Profit (loss) for the period 9904 €13,839 €329 -€13,510 -97.6%
Profit (loss) for the period to be appropriated 9905 €13,839 €329 -€13,510 -97.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.